Latest News about JNJ
Recent news which mentions JNJ
Merck’s $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology
April 17, 2023
From MarketWatch
Tickers
JNJ
From Motley Fool
From MarketWatch
2 Best Biotech Stocks to Buy for the Long Haul
April 17, 2023
From Motley Fool
The Fed Expects a Recession: 2 Warren Buffett Stocks to Buy Now and 1 to Avoid Like the Plague
April 17, 2023
From Motley Fool
2 of the Lowest-Risk Dividend Stocks in the World
April 16, 2023
From Motley Fool
Tesla, Netflix earnings due: Cheaper cars, cheaper content, more workout videos, as ‘earnings recession’ seems likely
April 16, 2023
From MarketWatch
Why Johnson & Johnson Is Such an Impressive Dividend Stock
April 15, 2023
Tickers
JNJ
From Motley Fool
3 Dividend Stocks to Buy for a Recession-Proof Portfolio
April 15, 2023
From InvestorPlace
3 Dividend Stocks to Buy and Hold for the Next Decade
April 15, 2023
From Motley Fool
Drug manufacturer Catalent’s stock tumbles 25% after profit warning and CFO departure
April 14, 2023
From MarketWatch
FDA Strikes Down Eli Lilly's Application Seeking Approval For Ulcerative Colitis Drug
April 14, 2023
From Benzinga
Why Johnson & Johnson Paying $8.9 Billion to Settle Its Talc Lawsuits Would Be Good News
April 14, 2023
Tickers
JNJ
From Motley Fool
Jeff Bezos, George Soros, Mark Cuban, and Ray Dalio All Have One Thing in Common: They're Making a Big Bet on This Industry
April 13, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 12, 2023
From Benzinga
From Motley Fool
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
April 11, 2023
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
April 11, 2023
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
April 11, 2023
From Benzinga
3 Blue-Chip Stocks to Buy at an All-Time Low in April
April 11, 2023
From InvestorPlace
Is Johnson & Johnson About to Put Its Talc Lawsuits to Bed?
April 11, 2023
Tickers
JNJ
From Motley Fool
An Investor's View of Johnson & Johnson's Talc Settlement
April 10, 2023
From Motley Fool
3 Best Stocks to Buy in April for the Looming Recession
April 10, 2023
From InvestorPlace
Morgan Stanley Maintains Equal-Weight Rating for Johnson & Johnson: Here's What You Need To Know
April 10, 2023
Tickers
JNJ
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.